BILOVET 200 MG/ML SOLUTION INJECTABLE
BILOVET 200 MG/ML SOLUTION INJECTABLE
Authorised
- Tylosin
Product identification
Medicine name:
BILOVET 200 MG/ML SOLUTION INJECTABLE
Active substance:
- Tylosin
Target species:
-
Cattle
-
Pig
-
Sheep
-
Goat
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Tylosin200.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal28day
-
Milk108hour
-
-
Pig
-
Meat and offal16day
-
-
Sheep
-
Milk108hour
-
Meat and offal42day
-
-
Goat
-
Meat and offal42day
-
Milk108hour
-
-
-
Intravenous use
-
Cattle
-
Meat and offal28day
-
Milk108hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Labiana Life Sciences S.A.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/8872066 1/2015
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/12/2023
fr-puar-600000040602-np-rpe174-fr.pdf
French (PDF)
Download Published on: 7/01/2026